Identification of BCL11B as a regulator of adipogenesis

被引:0
作者
Jun Inoue
Yusuke Ihara
Daisuke Tsukamoto
Keisuke Yasumoto
Tsutomu Hashidume
Kenya Kamimura
Yuji Nakai
Shigeki Hirano
Makoto Shimizu
Ryo Kominami
Ryuichiro Sato
机构
[1] Graduate School of Agricultural and Life Sciences,Department of Applied Biological Chemistry
[2] The University of Tokyo,Division of Gastroenterology and Hepatology
[3] Institute of Gerontology,Department of Medical Technology
[4] The University of Tokyo,Division of Molecular Biology, Department of Molecular Genetics
[5] Graduate School of Medical and Dental Sciences,undefined
[6] Niigata University,undefined
[7] Institute for Food Sciences,undefined
[8] Hirosaki University,undefined
[9] School of Health Sciences,undefined
[10] Faculty of Medicine,undefined
[11] Niigata University,undefined
[12] Graduate School of Medical and Dental Sciences,undefined
[13] Niigata University,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The differentiation of preadipocytes into adipocytes is controlled by several transcription factors, including peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-binding protein α (C/EBPα), which are known as master regulators of adipogenesis. BCL11B is a zinc finger-type transcription factor that regulates the development of the skin and central nervous and immune systems. Here, we found that BCL11B was expressed in the white adipose tissue (WAT), particularly the subcutaneous WAT and that BCL11B−/− mice had a reduced amount of subcutaneous WAT. During adipogenesis, BCL11B expression transiently increased in 3T3-L1 preadipocytes and mouse embryonic fibroblasts (MEFs). The ability for adipogenesis was reduced in BCL11B knockdown 3T3-L1 cells and BCL11B−/− MEFs, whereas the ability for osteoblastogenesis was unaffected in BCL11B−/− MEFs. Luciferase reporter gene assays revealed that BCL11B stimulated C/EBPβ activity. Furthermore, the expression of downstream genes of the Wnt/β-catenin signaling pathway was not suppressed in BCL11B−/− MEFs during adipogenesis. Thus, this study identifies BCL11B as a novel regulator of adipogenesis, which works, at least in part, by stimulating C/EBPβ activity and suppressing the Wnt/β-catenin signaling pathway.
引用
收藏
相关论文
共 88 条
[1]  
Mokdad AH(2001)The continuing epidemics of obesity and diabetes in the United States JAMA 286 1195-1200
[2]  
Laudes M(2011)Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes J. Mol. Endocrinol 46 R65-R72
[3]  
Farmer SR(2006)Transcriptional control of adipocyte formation Cell Metab 4 263-273
[4]  
Christodoulides C(2009)Adipogenesis and WNT signalling Trends Endocrinol. Metab. 20 16-24
[5]  
Lagathu C(2014)Regulation of Wnt/beta-catenin signaling by posttranslational modifications Cell Biosci 4 13-953
[6]  
Sethi JK(2000)Inhibition of adipogenesis by Wnt signaling Science 289 950-874
[7]  
Vidal-Puig A(2008)The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells Cell Prolif. 41 859-1801
[8]  
Gao C(2008)Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss Endocrinology 149 1793-10322
[9]  
Xiao G(2000)Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors J. Biol. Chem. 275 10315-603
[10]  
Hu J(2003)Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas Biochem. Biophys. Res. Commun. 301 598-563